Intraday BUY SELL Signals
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
CURE vs SPXL
CURE vs SPXL Comparison
Open Charts CURE vs SPXL
CURE vs SPXL Comparison Chart in %
Loading...
loading
loading
View a ticker or compare two or three
VS
VS
CURE vs. SPXL commentary
Aug 23, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURE is a StrongBuy and SPXL is a Hold.
SUMMARIES
FUNDAMENTALS
Fundamentals
SPXL has more net assets: 6.83B vs. CURE (203M). CURE (30.616) and SPXL (30.490) have matching annual dividend yield . CURE was incepted earlier than SPXL: CURE (15 years) vs SPXL (18 years). SPXL (0.84) has a lower expense ratio than CURE (0.94). SPXL has a higher turnover CURE (1.00) vs CURE (1.00).
| CURE | SPXL | CURE / SPXL | |
| Gain YTD | 30.616 | 30.490 | 100% |
| Net Assets | 203M | 6.83B | 3% |
| Total Expense Ratio | 0.94 | 0.84 | 112% |
| Turnover | 1.00 | 71.00 | 1% |
| Yield | 1.06 | 0.53 | 200% |
| Fund Existence | 15 years | 18 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| CURE | SPXL | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 90% | 3 days ago 88% |
| Stochastic ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Momentum ODDS (%) | 3 days ago 89% | 3 days ago 82% |
| MACD ODDS (%) | 3 days ago 90% | 3 days ago 82% |
| TrendWeek ODDS (%) | 3 days ago 90% | 3 days ago 88% |
| TrendMonth ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Advances ODDS (%) | 5 days ago 90% | 11 days ago 90% |
| Declines ODDS (%) | 10 days ago 90% | 6 days ago 88% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 90% | N/A |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RVPHX | 10.37 | 0.10 | +0.97% |
| Royce Smaller-Companies Growth Invmt | |||
| STMSX | 27.91 | 0.26 | +0.94% |
| SEI Tax-Managed Small/Mid Cap F (SIMT) | |||
| FOVBX | 77.93 | 0.71 | +0.92% |
| Fidelity Advisor Overseas A | |||
| RGGRX | 23.59 | 0.16 | +0.68% |
| Victory RS Global R6 | |||
| TRICX | 5.01 | 0.03 | +0.60% |
| Catalyst/SMH Total Return Income C | |||
CURE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CURE has been closely correlated with LLY. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURE jumps, then LLY could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | +3.35% | ||
| LLY - CURE | 72% Closely correlated | +0.88% | ||
| MRK - CURE | 69% Closely correlated | +2.39% | ||
| ABBV - CURE | 63% Loosely correlated | +1.20% | ||
| MDT - CURE | 60% Loosely correlated | +1.14% | ||
| BDX - CURE | 60% Loosely correlated | +2.33% | ||
More | ||||